550 related articles for article (PubMed ID: 27171264)
1. Ischemic postconditioning protects the heart against ischemia-reperfusion injury via neuronal nitric oxide synthase in the sarcoplasmic reticulum and mitochondria.
Hu L; Wang J; Zhu H; Wu X; Zhou L; Song Y; Zhu S; Hao M; Liu C; Fan Y; Wang Y; Li Q
Cell Death Dis; 2016 May; 7(5):e2222. PubMed ID: 27171264
[TBL] [Abstract][Full Text] [Related]
2. Myocardial Ischemic Postconditioning Promotes Autophagy against Ischemia Reperfusion Injury via the Activation of the nNOS/AMPK/mTOR Pathway.
Hao M; Zhu S; Hu L; Zhu H; Wu X; Li Q
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28287478
[TBL] [Abstract][Full Text] [Related]
3. Ischemic postconditioning regulates cardiomyocyte autophagic activity following ischemia/reperfusion injury.
Guo L; Xu JM; Mo XY
Mol Med Rep; 2015 Jul; 12(1):1169-76. PubMed ID: 25816157
[TBL] [Abstract][Full Text] [Related]
4. rAAV9-Mediated MEK1 Gene Expression Restores Post-conditioning Protection Against Ischemia Injury in Hypertrophic Myocardium.
Chen Y; Liu F; Chen BD; Li XM; Huang Y; Yu ZX; Gao XL; He CH; Yang YN; Ma YT; Gao XM
Cardiovasc Drugs Ther; 2020 Feb; 34(1):3-14. PubMed ID: 32103377
[TBL] [Abstract][Full Text] [Related]
5. Effect of eNOS on Ischemic Postconditioning-Induced Autophagy against Ischemia/Reperfusion Injury in Mice.
Shao J; Miao C; Geng Z; Gu M; Wu Y; Li Q
Biomed Res Int; 2019; 2019():5201014. PubMed ID: 30881990
[TBL] [Abstract][Full Text] [Related]
6. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin.
Bayrami G; Karimi P; Agha-Hosseini F; Feyzizadeh S; Badalzadeh R
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):174-183. PubMed ID: 28901167
[TBL] [Abstract][Full Text] [Related]
8. Loss of Protein Kinase Novel 1 (PKN1) is associated with mild systolic and diastolic contractile dysfunction, increased phospholamban Thr17 phosphorylation, and exacerbated ischaemia-reperfusion injury.
Francois AA; Obasanjo-Blackshire K; Clark JE; Boguslavskyi A; Holt MR; Parker PJ; Marber MS; Heads RJ
Cardiovasc Res; 2018 Jan; 114(1):138-157. PubMed ID: 29045568
[TBL] [Abstract][Full Text] [Related]
9. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial Dysfunction and Apoptosis Are Attenuated on κ-Opioid Receptor Activation Through AMPK/GSK-3β Pathway After Myocardial Ischemia and Reperfusion.
Tian X; Zhou Y; Wang Y; Zhang S; Feng J; Wang X; Guo H; Fan R; Feng N; Jia M; Gu X; Li J; Yang L; Wang Y; Li J; Zheng G; Fu F; Pei J
J Cardiovasc Pharmacol; 2019 Feb; 73(2):70-81. PubMed ID: 30422891
[TBL] [Abstract][Full Text] [Related]
11. Luteolin Enhances Sarcoplasmic Reticulum Ca2+-ATPase Activity through p38 MAPK Signaling thus Improving Rat Cardiac Function after Ischemia/Reperfusion.
Zhu S; Xu T; Luo Y; Zhang Y; Xuan H; Ma Y; Pan D; Li D; Zhu H
Cell Physiol Biochem; 2017; 41(3):999-1010. PubMed ID: 28222421
[TBL] [Abstract][Full Text] [Related]
12. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
Zhang J; Huang L; Shi X; Yang L; Hua F; Ma J; Zhu W; Liu X; Xuan R; Shen Y; Liu J; Lai X; Yu P
Aging (Albany NY); 2020 Nov; 12(23):24270-24287. PubMed ID: 33232283
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-22 contributes to myocardial ischemia-reperfusion injury by interfering with the mitochondrial function.
Du JK; Cong BH; Yu Q; Wang H; Wang L; Wang CN; Tang XL; Lu JQ; Zhu XY; Ni X
Free Radic Biol Med; 2016 Jul; 96():406-17. PubMed ID: 27174562
[TBL] [Abstract][Full Text] [Related]
14. ROS generated during early reperfusion contribute to intermittent hypobaric hypoxia-afforded cardioprotection against postischemia-induced Ca(2+) overload and contractile dysfunction via the JAK2/STAT3 pathway.
Wu L; Tan JL; Wang ZH; Chen YX; Gao L; Liu JL; Shi YH; Endoh M; Yang HT
J Mol Cell Cardiol; 2015 Apr; 81():150-61. PubMed ID: 25731682
[TBL] [Abstract][Full Text] [Related]
15. Trimetazidine Protects Cardiomyocytes Against Hypoxia/Reoxygenation Injury by Promoting AMP-activated Protein Kinase-dependent Autophagic Flux.
Zhong Y; Zhong P; He S; Zhang Y; Tang L; Ling Y; Fu S; Tang Y; Yang P; Luo T; Chen B; Chen A; Wang X
J Cardiovasc Pharmacol; 2017 Jun; 69(6):389-397. PubMed ID: 28581448
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation injury through AMPK/eNOS/PGC-1α signaling pathway.
Hu L; Zhou L; Wu X; Liu C; Fan Y; Li Q
Int J Clin Exp Pathol; 2014; 7(11):7378-88. PubMed ID: 25550773
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
18. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.
Vila-Petroff M; Salas MA; Said M; Valverde CA; Sapia L; Portiansky E; Hajjar RJ; Kranias EG; Mundiña-Weilenmann C; Mattiazzi A
Cardiovasc Res; 2007 Mar; 73(4):689-98. PubMed ID: 17217936
[TBL] [Abstract][Full Text] [Related]
19. Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction.
Hall AR; Burke N; Dongworth RK; Kalkhoran SB; Dyson A; Vicencio JM; Dorn GW; Yellon DM; Hausenloy DJ
Cell Death Dis; 2016 May; 7(5):e2238. PubMed ID: 27228353
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.
Tratsiakovich Y; Kiss A; Gonon AT; Yang J; Sjöquist PO; Pernow J
Diab Vasc Dis Res; 2017 May; 14(3):236-245. PubMed ID: 28183205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
